Burcon NutraScience Corporation
BU.TO · TSX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | CA$357 | CA$342 | CA$43 | CA$61 |
| % Growth | 4.4% | 699% | -30.4% | – |
| Cost of Goods Sold | CA$2,787 | CA$1,777 | CA$593 | CA$287 |
| Gross Profit | -CA$2,430 | -CA$1,434 | -CA$550 | -CA$226 |
| % Margin | -680.2% | -419.2% | -1,283.5% | -367.3% |
| R&D Expenses | CA$304 | CA$370 | CA$329 | CA$755 |
| G&A Expenses | CA$0 | CA$706 | CA$852 | CA$890 |
| SG&A Expenses | CA$207 | CA$737 | CA$883 | CA$923 |
| Sales & Mktg Exp. | CA$0 | CA$31 | CA$31 | CA$34 |
| Other Operating Expenses | CA$0 | -CA$66 | CA$179 | -CA$112 |
| Operating Expenses | CA$511 | CA$1,041 | CA$1,391 | CA$1,566 |
| Operating Income | -CA$2,941 | -CA$2,475 | -CA$1,941 | -CA$1,791 |
| % Margin | -823.3% | -723.4% | -4,531.3% | -2,913.4% |
| Other Income/Exp. Net | -CA$652 | -CA$1,000 | -CA$316 | CA$8 |
| Pre-Tax Income | -CA$3,593 | -CA$3,475 | -CA$2,257 | -CA$1,784 |
| Tax Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Net Income | -CA$3,593 | -CA$3,475 | -CA$2,257 | -CA$1,784 |
| % Margin | -1,005.9% | -1,015.5% | -5,268.8% | -2,901.1% |
| EPS | -0.28 | -0.27 | -0.23 | -0.006 |
| % Growth | -3.7% | -17.4% | -3,609.7% | – |
| EPS Diluted | -0.28 | -0.27 | -0.23 | -0.006 |
| Weighted Avg Shares Out | 12,688 | 12,688 | 9,934 | 285,272 |
| Weighted Avg Shares Out Dil | 12,688 | 12,688 | 9,934 | 285,272 |
| Supplemental Information | – | – | – | – |
| Interest Income | CA$36 | CA$59 | CA$33 | CA$5 |
| Interest Expense | CA$823 | CA$785 | CA$353 | CA$9 |
| Depreciation & Amortization | CA$682 | CA$66 | CA$49 | CA$72 |
| EBITDA | -CA$2,089 | -CA$2,409 | -CA$1,892 | -CA$1,719 |
| % Margin | -584.8% | -704.1% | -4,416.9% | -2,795.9% |